Ruby Lieshout

Publication Activity (10 Years)

Years Active: 2021-2022
Publications (10 Years): 4

Top Topics

Endoplasmic Reticulum Stress

Neoadjuvant Chemotherapy

Top Venues

British journal of cancer

Communications biology

International journal of cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Michael Koch, Sandra Nickel, Ruby Lieshout, Susanna M Lissek, Martina Leskova, Luc J W van der Laan, Monique M A Verstegen, Bruno Christ, Francesco Pampaloni
Label-Free Imaging Analysis of Patient-Derived Cholangiocarcinoma Organoids after Sorafenib Treatment. Cells 11 (22) (2022)
Guoying Zhou, Ruby Lieshout, Gilles S van Tienderen, Valeska de Ruiter, Martin E van Royen, Patrick P C Boor, Luc Magré, Jyaysi Desai, Kübra Köten, Yik Yang Kan, Zhouhong Ge, Lucia Campos Carrascosa, Cecile Geuijen, Dave Sprengers, Luc J W van der Laan, Monique M A Verstegen, Jaap Kwekkeboom
Modelling immune cytotoxicity for cholangiocarcinoma with tumour-derived organoids and effector T cells. British journal of cancer 127 (4) (2022)
Ruby Lieshout, Annemarie C de Vries, Monique M A Verstegen, Michail Doukas, Winand N M Dinjens, Kübra Köten, Jan N M IJzermans, Marco J Bruno, Maikel P Peppelenbosch, Luc J W van der Laan, Annemarie C de Vries
Cholangiocarcinoma cell proliferation is enhanced in primary sclerosing cholangitis: A role for IL-17A. International journal of cancer (2022)
Luan Nguyen, Myrthe Jager, Ruby Lieshout, Petra E de Ruiter, Mauro D Locati, Nicolle J M Besselink, Bastiaan R Van der Roest, Roel Janssen, Sander Boymans, Jeroen de Jonge, Jan Nicolaas Maria IJzermans, Michael Doukas, Monique M A Verstegen, Ruben van Boxtel, Luc J W van der Laan, Edwin Cuppen, Ewart W Kuijk
Precancerous liver diseases do not cause increased mutagenesis in liver stem cells. Communications biology 4 (1) (2021)